Asia Newsire: Press releases on Asia
(AsiaNewsWire.Net, December 06, 2018 ) The structural heart market was valued at US$ 6,406.3 in 2017 and is expected to reach US$ 13,850.2 Mn in 2025. The market is estimated to grow with a CAGR of 10.5% from 2017-2025.
In our study of structural heart the market is segmented into three major segments such as product, procedure, and end user. The product segment is divided into occluders, annuloplasty rings, heart valve balloons and others. The procedures segment consists of surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. Similarly, the end user is classified as hospitals and ambulatory surgical centers and cardiac centers.
Request for a sample copy of this report @ http://bit.ly/2J3fP50
The devices for the structural heart are designed to remold or repair the valvular heart abnormalities, defects and diseases. The market for the structural heart devices is developing as the prevalence for the structural heart diseases are estimated to be rising in the coming future. The targeted stakeholders for the reports include suppliers and distributors of structural heart devices and structural heart device manufacturing companies, hospitals and cardiac centers, healthcare professionals, ambulatory surgery centers and others.
Leading Market Players:
3. Boston Scientific Corporation
4. CryoLife, Inc
5. Edward Lifesciences Corporation
6. LivaNova Plc
7. Lepu Medical
8. Braile Biomedica
9. Labcor Laboratories Ltda
10. Aran Biomedical Teoranta
The objective or the scope the study was defining, describing, and forecasting the structural heart market on the basis of product, procedure, end user and region. In addition, analyzing the market structure, profiling the key players of the market, and comprehensively analyzing their core competencies. Tracking and analyzing competitive developments such as new product launches; market consolidations and clinical trials in the structural heart market. Moreover, the aim of the study was providing detailed information regarding the major factors or the reasons that are influencing the growth of the market in the five major regions such as North America, Europe, Asia Pacific, Middle East and Africa and South and Central America.
The market in different regions is analyzed by the PEST analysis and the SWOT analysis is provided for the profiled companies in our scope of study. For instance, the PEST analysis of the North America region contain political factor – tracking congenital heart defects (CHDs) programs, the economic factor - reimbursements plans for structural heart treatment, social factor – various fellowship programs in US, and the technological factor – developments for the treatment of severe aortic stenosis. Thus, the report provides all the major factors, such as drivers, restraints, opportunities, trends that are impacting the growth of the structural heart in the forecasted period.
The prominent players operating in the market include Abbott, Medtronic, Boston Scientific Corporation, CryoLife Ins, Edwards Lifesciences Corporation, LivaNova Plc, Lepu Medical, Braile Biomedica, Labcor Laboratorios Ltda, Aran Biomedical Teornta among others.
Reason to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global structural heart Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the structural heart Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Check Discount for this Report @ http://bit.ly/2J3mMTZ
Table of Contents:
1. INTRODUCTION 20
1.1 SCOPE OF THE STUDY 20
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 20
2. GLOBAL STRUCTURAL HEART MARKET – KEY TAKEAWAYS 21
3. GLOBAL STRUCTURAL HEART MARKET – MARKET LANDSCAPE 24
3.1 OVERVIEW 24
3.2 MARKET SEGMENTATION 24
3.3 GLOBAL STRUCTURAL HEART MARKET – BY PRODUCT 25
3.4 GLOBAL STRUCTURAL HEART MARKET – BY PROCEDURE 25
3.5 GLOBAL STRUCTURAL HEART MARKET – BY END USER 26
3.6 GLOBAL STRUCTURAL HEART MARKET – BY GEOGRAPHY 26
3.7 PEST ANALYSIS 27
3.7.1 North America – PEST Analysis 27
3.7.2 Europe – PEST Analysis 29
3.7.3 Asia Pacific – PEST Analysis 31
3.7.4 Middle East and Africa – PEST Analysis 33
3.7.5 South and Central America – PEST Analysis 35
4. GLOBAL STRUCTURAL HEART MARKET – KEY MARKET DYNAMICS 37
4.1 KEY MARKET DRIVERS 37
4.1.1 Innovative Structural Heart Services 37
4.1.2 Clinical Trials 37
4.1.3 Rise In The Number of Cardiovascular Procedure and Corresponding Training Programs 38
4.1.4 Changing Lifestyle Increasing Disease Burden 39
4.2 KEY MARKET RESTRAINTS 40
4.2.1 High Cost of Products and Procedures 40
4.2.2 Stringent Regulatory Procedures 40
4.3 KEY MARKET OPPORTUNITIES 41
4.3.1 Growth Opportunities In The Emerging Markets 41
4.4 FUTURE TRENDS 41
4.4.1 Technological Advancement 41
4.5 IMPACT ANALYSIS 42
The Insight Partners